As our understanding of resistance evolution continues to advance, such rationally designed regimens, grounded in robust preclinical evidence, will be instrumental in achieving durable responses and delaying disease progression across multiple cancer types
NF-KB pathway Enhanced canonical NF-kappaB signaling in macrophages is enough to reduce tumor progression in syngeneic mouse models of ovarian cancer by fostering an anti-tumor immune environment (49)
Published online July 31, 2025
Although there is some reciprocity for FedRAMP Moderate systems for IL-2 and FedRAMP High for IL-4, ensuring a system meets all the requirements as specified in DISAs DoD CC SRG requires a CSP to a sound plan and company investment
Post-screening characterisation and in vivo evaluation of an anti-inflammatory polysaccharide fraction from Eucommia ulmoides
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a stable fragment of a naturally occurring protein